Global Meningitis Vaccine Market Size By Vaccine Type(Meningococcal vaccine, Haemophilus influenza type b vaccine), By End-User(Adults and Children), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies), By Geographic Scope And Forecast

Meningitis Vaccine Market Size And Forecast

Meningitis Vaccine Market size was valued at USD 4,113.63 Million in 2021 and is projected to reach USD 6,683.12 Million by 2030, growing at a CAGR of 5.54% from 2023 to 2030.

Some of the key contributing factors propelling the growth of the Global Meningitis Vaccine Market are the increase in the incidence of meningitis in children and a rise in awareness about the benefits of immunization. The Global Meningitis Vaccine Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Meningitis Vaccine Market Definition

Meningitis is an infection affecting the delicate membranes called meninges that cover the brain and spinal cord. It leads to inflammation of the brain and spinal cord membranes. Meningitis causes severe fever, headache, and pain in the neck, back, and muscles. Meningitis is usually viral but can also be bacterial, fungal or parasitic. Some cases of meningitis improve without treatment within a couple of weeks.

However, it can be life-threatening and at times need emergency antibiotic treatment. Bacterial meningitis is intense and can be fatal. When untreated, it can lead to permanent disabilities like brain damage and hearing loss. However, the majority of meningitis instances can be prevented with proper vaccination. Immunization can also help to protect against bacterial meningitis.

Global Meningitis Vaccine Market Overview

The rising instances of meningitis disease are an important driver for the Global Meningitis Vaccine Market. There has been an increase in the incidence of meningitis in children which can cause permanent disabilities in them. Another major factor propelling the growth in the global Meningitis Vaccine Market is the rising government interventions to combat the growing cases of meningitis and increasing healthcare expenditure. Other important drivers are the rising health awareness among the population and growing knowledge about the proper dose of immunization and its benefits.

The growing demand for advanced vaccines in emerging nations is expected to provide new profitable opportunities leading to the rapid growth of the Meningitis Vaccine Market. Also, the boost in research and development in the healthcare sector to develop cost-effective vaccines for the consumers will provide an opportunity for the growth of the Meningitis Vaccine Market.

Other opportunities lie in the expanding National Immunization Programs (NIPs) organized by various governments which are supported by global organizations and nonprofit organizations. Thus, there are ample growth opportunities for the market. However, there are some restraints like the bacterial resistance to penicillin and lack of access to vaccine approval from regulatory authorities. These may adversely impact the growth of the Meningitis Vaccine Market.

Global Meningitis Vaccine MarketSegmentation Analysis

The Global Meningitis Vaccine Market is segmented based on Vaccine Type, End-User, Distribution Channel, And Geography.

Meningitis Vaccine Market, By Vaccine Type

• Meningococcal vaccine• Haemophilus influenza type b vaccine• Pneumococcal conjugate vaccine• Pneumococcal polysaccharide vaccine• Others

By Vaccine Type, The market is segmented into Meningococcal vaccine, Haemophilus influenza type b vaccine, Pneumococcal conjugate vaccine, Pneumococcal polysaccharide vaccine, and Others. The meningococcal vaccine segment is likely to grow at a fast rate going forward. This is since it can protect from four classes of bacteria that can cause meningitis.

Meningitis Vaccine Market, By End-User

• Adults• Children

By End-User, The market is segmented into Adults and Children. The children segment has the majority of market share and is expected to grow at a faster rate over the upcoming years as bacterial meningitis mostly affects children.

Meningitis Vaccine Market, By Distribution Channel

• Hospital Pharmacies• Retail Pharmacies• Others

By Distribution Channel, The market is segmented into Hospital Pharmacies, Retail Pharmacies, and Others. The hospital pharmacies segment has the majority of market share as several types of vaccines are widely available in hospital pharmacies.

Meningitis Vaccine Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

By geography, The Global Meningitis Vaccine Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America holds the highest share of the global Meningitis Vaccine market. This is owing to the increasing healthcare expenditure, growing advancement in the healthcare infrastructure, and rising awareness regarding meningitis by various immunization programs. The Asia Pacific market is expected to grow fast due to the increasing population, rising demand for advanced vaccines in emerging economies such as India, China, etc. and growing healthcare awareness to minimize the instances of diseases.

Key Players

The “Global Meningitis Vaccine Market” study report will provide a valuable insight with an emphasis on the global market. The major players in the market are GlaxoSmithKline, Pfizer Inc., Merck & Co. Inc., Sanofi Pasteur SA, Astellas Pharma Inc., CSL Limited, Emergent BioSolutions Inc., Johnson & Johnson, Serum Institute of India Pvt. Ltd., and Panacea Biotec.

The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

Partnerships, Collaborations and Agreements

• In January 2019, two long-term collaboration agreements with the Indian Serum Institute Pvt. Ltd., the largest vaccine manufacturer and the largest wholly-owned subsidiary of the world SII, Bilthovan Biologicals B.V., were signed by Panacea Biotec Ltd., the leading Indian organic pharmaceutical company (BBIO).

Mergers and Acquisitions

• Johnson & Johnson, a company discovering and developing new therapies for immune-reduced diseases, successfully completed its acquisition of Momenta Pharmaceuticals in a cash transaction of approximately $6.5 billion in October 2020.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.